Recursion Pharmaceuticals (RXRX) has been drawing attention after recent trading, with the stock closing at $4.67. Investors are weighing this price against the company’s clinical pipeline and ongoing ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more ...

Security researchers have discovered a new indirect prompt injection vulnerability that tricks AI browsers into performing malicious actions. Cato Networks claimed that “HashJack” is the first ...

Funding direct costs supports the expenses that can be specifically identified with a particular project such as researchers, supplies and travel. Funding indirect costs supports the critical ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

Matthew Macfadyen and Keira Knightley as Darcy and Elizabeth Bennett in the 2005 screen adaptation of Pride and Prejudice. FilmAffinity At the beginning of Pride and Prejudice, Jane Austen’s most well ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...

Have you ever found yourself frustrated with an Excel workbook that seems to lag, break, or throw errors at the worst possible time? If so, there’s a good chance the culprit is one of Excel’s most ...

GENEVA, June 5 (Reuters) - Indirect carbon emissions from the operations of four of the leading AI-focused tech companies rose on average by 150% from 2020-2023, due to the demands of power-hungry ...

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) fell this week. The stock lost 24% as of market close on Friday. The move comes as the S&P 500 and Nasdaq Composite both slipped slightly. Recursion ...